Association between aberrant APC promoter methylation and breast cancer pathogenesis: a meta-analysis of 35 observational studies

Background. Adenomatous polyposis coli (APC) is widely known as an antagonist of the Wnt signaling pathway via the inactivation of β-catenin. An increasing number of studies have reported that APC methylation contributes to the predisposition to breast cancer (BC). However, recent studies have yield...

Full description

Bibliographic Details
Main Authors: Dan Zhou, Weiwei Tang, Wenyi Wang, Xiaoyan Pan, Han-Xiang An, Yun Zhang
Format: Article
Language:English
Published: PeerJ Inc. 2016-07-01
Series:PeerJ
Subjects:
Online Access:https://peerj.com/articles/2203.pdf
_version_ 1797417661181722624
author Dan Zhou
Weiwei Tang
Wenyi Wang
Xiaoyan Pan
Han-Xiang An
Yun Zhang
author_facet Dan Zhou
Weiwei Tang
Wenyi Wang
Xiaoyan Pan
Han-Xiang An
Yun Zhang
author_sort Dan Zhou
collection DOAJ
description Background. Adenomatous polyposis coli (APC) is widely known as an antagonist of the Wnt signaling pathway via the inactivation of β-catenin. An increasing number of studies have reported that APC methylation contributes to the predisposition to breast cancer (BC). However, recent studies have yielded conflicting results. Methods. Herein, we systematically carried out a meta-analysis to assess the correlation between APC methylation and BC risk. Based on searches of the Cochrane Library, PubMed, Web of Science and Embase databases, the odds ratio (OR) with 95% confidence interval (CI) values were pooled and summarized. Results. A total of 31 articles involving 35 observational studies with 2,483 cases and 1,218 controls met the inclusion criteria. The results demonstrated that the frequency of APC methylation was significantly higher in BC cases than controls under a random effect model (OR = 8.92, 95% CI [5.12–15.52]). Subgroup analysis further confirmed the reliable results, regardless of the sample types detected, methylation detection methods applied and different regions included. Interestingly, our results also showed that the frequency of APC methylation was significantly lower in early-stage BC patients than late-stage ones (OR = 0.62, 95% CI [0.42–0.93]). Conclusion. APC methylation might play an indispensable role in the pathogenesis of BC and could be regarded as a potential biomarker for the diagnosis of BC.
first_indexed 2024-03-09T06:21:53Z
format Article
id doaj.art-6b67fe56dc0f488d9b854caa477fcd60
institution Directory Open Access Journal
issn 2167-8359
language English
last_indexed 2024-03-09T06:21:53Z
publishDate 2016-07-01
publisher PeerJ Inc.
record_format Article
series PeerJ
spelling doaj.art-6b67fe56dc0f488d9b854caa477fcd602023-12-03T11:35:55ZengPeerJ Inc.PeerJ2167-83592016-07-014e220310.7717/peerj.2203Association between aberrant APC promoter methylation and breast cancer pathogenesis: a meta-analysis of 35 observational studiesDan Zhou0Weiwei Tang1Wenyi Wang2Xiaoyan Pan3Han-Xiang An4Yun Zhang5Department of Translational Medicine, Xiamen Institute of Rare Earth Materials, Xiamen, ChinaDepartment of Medical Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, ChinaDepartment of Medical Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, ChinaDepartment of Medical Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, ChinaDepartment of Medical Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, ChinaDepartment of Translational Medicine, Xiamen Institute of Rare Earth Materials, Xiamen, ChinaBackground. Adenomatous polyposis coli (APC) is widely known as an antagonist of the Wnt signaling pathway via the inactivation of β-catenin. An increasing number of studies have reported that APC methylation contributes to the predisposition to breast cancer (BC). However, recent studies have yielded conflicting results. Methods. Herein, we systematically carried out a meta-analysis to assess the correlation between APC methylation and BC risk. Based on searches of the Cochrane Library, PubMed, Web of Science and Embase databases, the odds ratio (OR) with 95% confidence interval (CI) values were pooled and summarized. Results. A total of 31 articles involving 35 observational studies with 2,483 cases and 1,218 controls met the inclusion criteria. The results demonstrated that the frequency of APC methylation was significantly higher in BC cases than controls under a random effect model (OR = 8.92, 95% CI [5.12–15.52]). Subgroup analysis further confirmed the reliable results, regardless of the sample types detected, methylation detection methods applied and different regions included. Interestingly, our results also showed that the frequency of APC methylation was significantly lower in early-stage BC patients than late-stage ones (OR = 0.62, 95% CI [0.42–0.93]). Conclusion. APC methylation might play an indispensable role in the pathogenesis of BC and could be regarded as a potential biomarker for the diagnosis of BC.https://peerj.com/articles/2203.pdfBreast cancerAPCMethylationMeta-analysis
spellingShingle Dan Zhou
Weiwei Tang
Wenyi Wang
Xiaoyan Pan
Han-Xiang An
Yun Zhang
Association between aberrant APC promoter methylation and breast cancer pathogenesis: a meta-analysis of 35 observational studies
PeerJ
Breast cancer
APC
Methylation
Meta-analysis
title Association between aberrant APC promoter methylation and breast cancer pathogenesis: a meta-analysis of 35 observational studies
title_full Association between aberrant APC promoter methylation and breast cancer pathogenesis: a meta-analysis of 35 observational studies
title_fullStr Association between aberrant APC promoter methylation and breast cancer pathogenesis: a meta-analysis of 35 observational studies
title_full_unstemmed Association between aberrant APC promoter methylation and breast cancer pathogenesis: a meta-analysis of 35 observational studies
title_short Association between aberrant APC promoter methylation and breast cancer pathogenesis: a meta-analysis of 35 observational studies
title_sort association between aberrant apc promoter methylation and breast cancer pathogenesis a meta analysis of 35 observational studies
topic Breast cancer
APC
Methylation
Meta-analysis
url https://peerj.com/articles/2203.pdf
work_keys_str_mv AT danzhou associationbetweenaberrantapcpromotermethylationandbreastcancerpathogenesisametaanalysisof35observationalstudies
AT weiweitang associationbetweenaberrantapcpromotermethylationandbreastcancerpathogenesisametaanalysisof35observationalstudies
AT wenyiwang associationbetweenaberrantapcpromotermethylationandbreastcancerpathogenesisametaanalysisof35observationalstudies
AT xiaoyanpan associationbetweenaberrantapcpromotermethylationandbreastcancerpathogenesisametaanalysisof35observationalstudies
AT hanxiangan associationbetweenaberrantapcpromotermethylationandbreastcancerpathogenesisametaanalysisof35observationalstudies
AT yunzhang associationbetweenaberrantapcpromotermethylationandbreastcancerpathogenesisametaanalysisof35observationalstudies